Comparative Evaluation of Disk Diffusion with Microdilution Assay in Susceptibility Testing of Caspofungin against Aspergillus and Fusarium Isolates
Open Access
- 1 September 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9), 3084-3087
- https://doi.org/10.1128/aac.46.9.3084-3087.2002
Abstract
We compared the disk diffusion and broth microdilution methods for susceptibility testing of caspofungin against Aspergillus ( n = 78) and Fusarium ( n = 22) isolates. Microdilution testing followed the NCCLS M-38P guidelines but was performed in antibiotic medium 3 supplemented to 2% glucose (AM3). Disk diffusion assays were performed on AM3 agar plates with a 2-μg caspofungin disk. By both methods, caspofungin showed favorable activity against Aspergillus isolates and no activity against Fusarium isolates. In the disk-based format, intrazonal growth that was not influenced by the drug concentration gradient was consistently observed for all of the Aspergillus isolates tested.Keywords
This publication has 19 references indexed in Scilit:
- Utility of 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenyl-Amino)Carbonyl]-2 H -Tetrazolium Hydroxide (XTT) and Minimum Effective Concentration Assays in the Determination of Antifungal Susceptibility of Aspergillus fumigatus to the Lipopeptide Class of CompoundsJournal of Clinical Microbiology, 2001
- Correlation between Antifungal Susceptibilities of Coccidioides immitis In Vitro and Antifungal Treatment with Caspofungin in a Mouse ModelAntimicrobial Agents and Chemotherapy, 2001
- Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitorsExpert Opinion on Investigational Drugs, 2001
- In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium IsolatesAntimicrobial Agents and Chemotherapy, 2001
- Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin BJournal of Antimicrobial Chemotherapy, 2000
- New investigational antifungal agents for treating invasive fungal infectionsExpert Opinion on Investigational Drugs, 2000
- New agents for treatment of systemic fungal infectionsEmerging Drugs, 2000
- Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase InhibitorsAntimicrobial Agents and Chemotherapy, 2000
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373Antimicrobial Agents and Chemotherapy, 1995